Long-Term Outcome in Gastric Cancer Patients with Different Body Composition Score Assessed via Computed Tomography

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Yang L, Zheng R, Wang N, et al. Incidence and mortality of stomach cancer in China, 2014. Chin J Cancer Res. 2018;30(3):291–298. doi:10.21147/j.issn.1000-9604.2018.03.01.
   PubMed Web of Science ®Google Scholar
• Jeong O, Kyu Park Y, Ran Jung M, et al. Analysis of 30-day postdischarge morbidity and readmission after radical gastrectomy for gastric carcinoma: a single-center study of 2107 patients with prospective data. Medicine (Baltimore) 2015;94(11):e259. doi:10.1097/MD.0000000000000259.
   PubMed Web of Science ®Google Scholar
• Stratilatovas E, Bausys A, Bausys R, et al. Mortality after gastrectomy: a 10 year single institution experience. Acta Chirurgica Belgica 2015;115(2):123–130. doi:10.1080/00015458.2015.11681081.
   PubMed Web of Science ®Google Scholar
• Arends J, Baracos V, Bertz H, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. (Edinburgh, Scotland). 2017;36(5):1187–1196. doi:10.1016/j.clnu.2017.06.017.
   PubMed Web of Science ®Google Scholar
• Fukuda Y, Yamamoto K, Hirao M, et al. Prevalence of malnutrition among gastric cancer patients undergoing gastrectomy and optimal preoperative nutritional support for preventing surgical site infections. Ann Surg Oncol. 2015;22 (S3):778–785. doi:10.1245/s10434-015-4820-9.
   Web of Science ®Google Scholar
• Marshall KM, Loeliger J, Nolte L, et al. Prevalence of malnutrition and impact on clinical outcomes in cancer services: a comparison of two time points. Clin Nutr. (Edinburgh, Scotland). 2019;38(2):644–651. doi:10.1016/j.clnu.2018.04.007.
   PubMed Web of Science ®Google Scholar
• Weimann A, Braga M, Carli F, et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr. (Edinburgh, Scotland). 2017;36(3):623–650. doi:10.1016/j.clnu.2017.02.013.
   PubMed Web of Science ®Google Scholar
• Mortensen K, Nilsson M, Slim K, et al.; The Enhanced Recovery After Surgery (ERAS®) Group. Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations. Br J Surg. 2014;101(10):1209–1229. doi:10.1002/bjs.9582.
   PubMed Web of Science ®Google Scholar
• Fujiya K, Kawamura T, Omae K, et al. Impact of malnutrition after gastrectomy for gastric cancer on long-term survival. Ann Surg Oncol. 2018;25(4):974–983. doi:10.1245/s10434-018-6342-8.
   PubMed Web of Science ®Google Scholar
• Loan BTH, Nakahara S, Tho BA, et al. Nutritional status and postoperative outcomes in patients with gastrointestinal cancer in Vietnam: a retrospective cohort study. Nutrition 2018;48:117–121. doi:10.1016/j.nut.2017.11.027.
   PubMed Web of Science ®Google Scholar
• Guo ZQ, Yu JM, Li W, et al. Survey and analysis of the nutritional status in hospitalized patients with malignant gastric tumors and its influence on the quality of life. Support Care Cancer 2020;28(1):373–380. doi:10.1007/s00520-019-04803-3.
   PubMed Web of Science ®Google Scholar
• Chen XY, Zhang XZ, Ma BW, et al. A comparison of four common malnutrition risk screening tools for detecting cachexia in patients with curable gastric cancer. Nutrition 2020;70:110498. doi:10.1016/j.nut.2019.04.009.
   PubMed Web of Science ®Google Scholar
• Blum D, Strasser F. Cachexia assessment tools. Curr Opin Support Palliat Care 2011;5(4):350–355. doi:10.1097/SPC.0b013e32834c4a05.
   PubMedGoogle Scholar
• van Vugt JL, Levolger S, Gharbharan A, et al. A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients. J Cachexia Sarcopenia Muscle 2017;8(2):285–297. doi:10.1002/jcsm.12158.
   PubMed Web of Science ®Google Scholar
• Sano T, Aiko T. New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer 2011;14(2):97–100. doi:10.1007/s10120-011-0040-6.
   PubMed Web of Science ®Google Scholar
• Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240(2):205–213. doi:10.1097/01.sla.0000133083.54934.ae.
   PubMed Web of Science ®Google Scholar
• Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. Cancer J Clin. 2017;67(2):93–99. doi:10.3322/caac.21388.
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Nakagawa H, Kudo Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63(1):131–140. doi:10.1016/j.jhep.2015.02.031.
   PubMed Web of Science ®Google Scholar
• Yip C, Goh V, Davies A, et al. Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. Eur Radiol. 2014;24(5):998–1005. doi:10.1007/s00330-014-3110-4.
   PubMed Web of Science ®Google Scholar
• Park HS, Kim HS, Beom SH, et al. Marked loss of muscle, visceral fat, or subcutaneous fat after gastrectomy predicts poor survival in advanced gastric cancer: single-center study from the CLASSIC Trial. Ann Surg Oncol. 2018;25(11):3222–3230. doi:10.1245/s10434-018-6624-1.
   PubMed Web of Science ®Google Scholar
• Hacker UT, Hasenclever D, Linder N, et al. Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial. J Cachexia Sarcopenia Muscle. doi:10.1002/jcsm.12484.
   Web of Science ®Google Scholar
• Harada K, Baba Y, Ishimoto T, et al. Low visceral fat content is associated with poor prognosis in a database of 507 upper gastrointestinal cancers. Ann Surg Oncol. 2015;22(12):3946–3953. doi:10.1245/s10434-015-4432-4.
   PubMed Web of Science ®Google Scholar
• Kawamura T, Makuuchi R, Tokunaga M, et al. Long-term outcomes of gastric cancer patients with preoperative sarcopenia. Ann Surg Oncol. 2018;25(6):1625–1632. doi:10.1245/s10434-018-6452-3.
   PubMed Web of Science ®Google Scholar
• Zhuang C-L, Huang D-D, Pang W-Y, et al. Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer. Medicine 2016;95(13):e3164. doi:10.1097/MD.0000000000003164.
   PubMed Web of Science ®Google Scholar
• Zheng ZF, Lu J, Zheng CH, et al. A novel prognostic scoring system based on preoperative sarcopenia predicts the long-term outcome for patients after r0 resection for gastric cancer: experiences of a high-volume center. Ann Surg Oncol. 2017;24(7):1795–1803. doi:10.1245/s10434-017-5813-7.
   PubMed Web of Science ®Google Scholar
• Sakurai K, Kubo N, Tamura T, et al. Adverse effects of low preoperative skeletal muscle mass in patients undergoing gastrectomy for gastric cancer. Ann Surg Oncol. 2017;24(9):2712–2719. doi:10.1245/s10434-017-5875-6.
   PubMed Web of Science ®Google Scholar
• Huang DD, Zhou CJ, Wang SL, et al. Impact of different sarcopenia stages on the postoperative outcomes after radical gastrectomy for gastric cancer. Surgery 2017;161(3):680–693. doi:10.1016/j.surg.2016.08.030.
   PubMed Web of Science ®Google Scholar
• Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res. 1999;59(18):4493–4501.
   PubMed Web of Science ®Google Scholar
• Mantovani G, Maccio A, Lai P, et al. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Crit Rev Oncol. 1998;25(2 Suppl 6):45–52. doi:10.1615/CritRevOncog.v9.i2.10.
   Google Scholar
• Moldawer LL, Copeland EM. 3rd. Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options. Cancer 1997;79(9):1828–1839. doi:10.1002/(SICI)1097-0142(19970501)79:9<1828::AID-CNCR28>3.0.CO;2-Z.
   PubMed Web of Science ®Google Scholar
• Brown JL, Lee DE, Rosa-Caldwell ME, et al. Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice. J Cachexia Sarcopenia Muscle 2018;9(5):987–1002. doi:10.1002/jcsm.12354.
   PubMed Web of Science ®Google Scholar
• Murphy RA, Wilke MS, Perrine M, et al. Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients. Clin Nutr. (Edinburgh, Scotland). 2010;29(4):482–487. doi:10.1016/j.clnu.2009.11.006.
   PubMed Web of Science ®Google Scholar
• Ebadi M, Mazurak VC. Evidence and mechanisms of fat depletion in cancer. Nutrients 2014;6(11):5280–5297. doi:10.3390/nu6115280.
   PubMed Web of Science ®Google Scholar
• Mourtzakis M, Prado CM, Lieffers JR, et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):997–1006. doi:10.1139/H08-075.
   PubMed Web of Science ®Google Scholar
• Kuwada K, Kuroda S, Kikuchi S, et al. Sarcopenia and comorbidity in gastric cancer surgery as a useful combined factor to predict eventual death from other causes. Ann Surg Oncol. 2018;25(5):1160–1166. doi:10.1245/s10434-018-6354-4.
   PubMed Web of Science ®Google Scholar
• Takeda Y, Akiyoshi T, Matsueda K, et al. Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy. PLoS One 2018;13(4):e0195406. doi:10.1371/journal.pone.0195406.
   PubMed Web of Science ®Google Scholar